Skip to main content

Advertisement

Table 3 Clinical assessment at baseline and 90 days after viscosupplementation

From: Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study

  Baseline Day 90 Baseline vs. Day 90 P value
WOMAC Pain 26.0 (7.0–42.0) 16.5 (0.0–46.0) <0.0001
WOMAC Stiffness 10.0 (0.0–18.0) 6.0 (0.0–17.0) <0.0001
WOMAC Function 84.0 (23.0–134.0) 58.0 (0.0–133.0) <0.0001
PGA 7.0 (3.0–10.0) 5.0 (0.0–10.0) <0.0001
  1. Data are median (range) or percentage of cases. Each WOMAC item was measured on a 11-point Likert scale
  2. PGA, patient global assessment